DONOR T-CELLS SPECIFIC FOR HEMATOPOIETIC-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS ARE INDUCED IN PATIENTS IN WHICH GRAFT-VERSUS-LEUKEMIA REACTIVITY IS ACCOMPANIED WITH GRAFT-VERSUS-HOST DISEASE

被引：0
|
作者：
Pont, M. [1 ]
Lurvink, E. [1 ]
Van Bergen, C. [1 ]
Honders, M. [1 ]
van Luxemburg-Heijs, S. [1 ]
Kester, M. [1 ]
Falkenburg, J. [1 ]
Griffioen, M. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0092
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [41] Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease
    Spaapen, Robbert
    Mutis, Tuna
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (03) : 543 - 557
  • [42] Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells
    Coghill, James M.
    Carlson, Michael J.
    Panoskaltsis-Mortari, Angela
    West, Michelle L.
    Burgents, Joseph E.
    Blazar, Bruce R.
    Serody, Jonathan S.
    BLOOD, 2010, 115 (23) : 4914 - 4922
  • [43] Graft Versus Leukemia Response Without Graft-versus-host Disease Elicited By Adoptively Transferred Multivirus-specific T-cells
    Melenhorst, Jan J.
    Castillo, Paul
    Hanley, Patrick J.
    Keller, Michael D.
    Krance, Robert A.
    Margolin, Judith
    Leen, Ann M.
    Heslop, Helen E.
    Barrett, A. John
    Rooney, Cliona M.
    Bollard, Catherine M.
    MOLECULAR THERAPY, 2015, 23 (01) : 179 - 183
  • [44] Nanoparticle-Encapsulated Allogeneic T Cells Mitigate Graft-Versus-Host Disease but Retain Graft-Versus-Leukemia Activity
    Zhang, Lingling
    Zhao, Shuting
    Devine, Steven M.
    He, Xiaoming
    Yu, Jianhua
    BLOOD, 2014, 124 (21)
  • [45] Central Memory CD8+ T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia
    Zheng, Hong
    Matte-Martone, Catherine
    Jain, Dhanpat
    McNiff, Jennifer
    Shlomchik, Warren D.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (10): : 5938 - 5948
  • [46] MINOR HISTOCOMPATIBILITY ANTIGENS AS DETERMINANTS FOR GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Turpeinen, Hannu
    Ojala, Pauli
    Volin, Liisa
    Partanen, Jukka
    TISSUE ANTIGENS, 2012, 79 (06): : 461 - 462
  • [47] Transplantation of polarized type 2 donor T cells reduces mortality from graft-versus-host disease to minor histocompatibility antigens.
    Krenger, W
    Cooke, KR
    Crawford, JM
    Sonis, ST
    Simmons, R
    Pan, L
    Delmonte, J
    Karandikar, M
    Ferrara, JLM
    BLOOD, 1996, 88 (10) : 2692 - 2692
  • [48] Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response
    Jones, SC
    Murphy, GF
    Korngold, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (04) : 243 - 256
  • [49] Effect of FK506 on donor T-CELL functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect
    Imado, T
    Iwasaki, T
    Kuroiwa, T
    Sano, H
    Hara, H
    TRANSPLANTATION, 2004, 77 (03) : 391 - 398
  • [50] Segregation of a graft-versus-leukemia effect from graft-versus-host disease by the modulation of donor CD8+ T cell activity
    Cho, Hong R.
    Kim, Juyang
    Lee, Jong S.
    Kwon, Byungsuk
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 506 - 506
12345